MedTrace Logo

Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients

NCT01682460 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-06-05

Study results available
· View outcomes & findings →

Summary

Research indicates that many people who are being treated for glaucoma have dry eyes. The purpose of this study is to test the use of artificial tears to alleviate dryness signs and symptoms in people who are using medication to treat glaucoma. The study hypothesis is that the use of artificial tears will result in an improvement in clinical signs and symptoms associated with dry eyes.

Conditions

Interventions

DRUG

Refresh Tears Lubricant Eye Drops (Allergan)

Eye drops QID for 1 month

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • University of Waterloo

    lead OTHER

Principal Investigators

  • Lyndon Jones, PhD · University of Waterloo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01682460 on ClinicalTrials.gov